OKYO Pharma to Ring the Opening Bell at Nasdaq
OKYO Pharma to Ring the Opening Bell at Nasdaq GlobeNewswire December 19, 2025 LONDON and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without […]